Loading...
Loading...
Indiana has the second-highest manufacturing output per capita in the United States, and that ranking is anchored by a vehicle assembly ecosystem that few states can match. Subaru of Indiana Automotive in Lafayette, Toyota Motor Manufacturing Indiana in Princeton, and Honda Manufacturing of Indiana in Greensburg collectively produce more than a million vehicles annually and represent the kind of continuous-flow assembly environment where AI quality inspection and predictive maintenance are not aspirational — they are the baseline for staying on a Japanese OEM's approved supplier list. But Indiana manufacturing in 2025 is not just about vehicles. Eli Lilly's extraordinary $9 billion-plus commitment to expand pharmaceutical manufacturing in Indiana — centered on a new facility in Lebanon and upgrades across their Indianapolis-area footprint — is creating a second major AI adoption wave in the state, this one driven by FDA quality system requirements rather than automotive traceability standards. Cummins Inc. in Columbus has been one of the quietest but most systematic corporate adopters of AI in manufacturing anywhere in the Midwest, applying machine learning to engine assembly quality, predictive maintenance on their global supplier base, and AI-driven emissions compliance monitoring. The Indiana Economic Development Corporation and Purdue University's MEP program, operated through the Indiana Manufacturing Competitiveness Center, provide the infrastructure through which smaller Indiana manufacturers — the auto parts suppliers in Kokomo and Anderson, the pharma contract manufacturers around Indianapolis — can access AI readiness support without a six-figure consulting engagement.
Subaru of Indiana Automotive, Toyota Princeton, and Honda Greensburg do not just assemble vehicles — they set quality and traceability standards that cascade through every tier of their supply chains, and those supply chains run deep into Indiana. The Kokomo automotive parts corridor — including Stellantis Kokomo Transmission, Haynes International, and a dense cluster of stamping, casting, and electronics suppliers — has been navigating increasing quality data requirements from Japanese OEM customers for several years. AI computer vision inspection systems on stamping and welding lines are now standard at the largest Indiana auto suppliers; the conversation at the tier-two level is catching up. Toyota's Production System influence at Princeton creates particularly detailed quality documentation expectations — Toyota's Global Production System requirements for statistical process control and defect-density tracking are being enforced at supplier audit level in ways that specifically flag manual data collection as a compliance gap. Honda's Greensburg plant has been running predictive maintenance pilots on their own stamping equipment, and their supplier quality team has been communicating that expectation downstream. Subaru's Lafayette complex, which assembles the Outback, Legacy, and Ascent for the North American market, runs one of the more sophisticated AI-assisted weld inspection systems among Indiana's vehicle assembly plants — operators there report that the shift from human weld inspectors to AI vision systems has reduced escape rates by measurable percentages while simultaneously handling the inspection volume a human team could not sustain at full production cadence.
Eli Lilly's decision to concentrate its massive pharmaceutical manufacturing expansion in Indiana — rather than distributing it globally — is the most consequential single investment in Indiana manufacturing history, and it is reshaping the AI landscape for the state's pharmaceutical and biomanufacturing sector. The Lebanon, Indiana greenfield facility, Lilly's Concord facility in Clinton, and upgrades to their Indianapolis operations collectively represent a scale of pharmaceutical manufacturing buildout that has not been seen in any single state in recent years. The FDA regulatory context is critical here: Lilly's manufacturing operations are subject to FDA's Current Good Manufacturing Practices under 21 CFR Parts 210 and 211, and the agency's recent emphasis on process analytical technology and data integrity has made AI-assisted process monitoring a compliance expectation rather than just an efficiency tool. Smaller Indiana pharma contract manufacturers clustered around Indianapolis — including Cook Pharmica in Bloomington and several smaller contract development and manufacturing organizations — are facing similar FDA pressure and are actively looking for AI implementation partners who understand the FDA validation requirements (per 21 CFR Part 11 and the agency's Computer Software Assurance guidance) that govern how AI systems are qualified for pharmaceutical manufacturing use. The Indiana Biosciences Research Institute in Indianapolis provides a local knowledge anchor for the AI-pharma-manufacturing intersection, and Purdue University's pharmaceutical engineering program trains the workforce that will operate these AI systems. In practice, the gap between what Lilly's validated process monitoring infrastructure looks like and what a 60-person contract manufacturer in Greenfield, Indiana can afford is where the MEP support programs make the biggest difference.
Cummins Inc. in Columbus, Indiana has been running one of the more disciplined AI-in-manufacturing programs among midsize Indiana industrial companies. Their work on AI-driven engine assembly quality inspection — particularly on high-tolerance fuel system and aftertreatment components where field failure costs are enormous — has been presented at multiple manufacturing technology conferences. Cummins' Columbus operations have also deployed ML predictive maintenance on their foundry and machining lines, using vibration, temperature, and current-draw data to predict bearing and tooling failures before they interrupt production. Their emissions compliance AI work, tracking real-time combustion parameter data against EPA Tier 4 Final and Stage V standards, represents a manufacturing AI use case that few other Indiana companies have. For the broader Indiana manufacturing base, Purdue University's Manufacturing Extension Partnership program — operated through the Indiana Manufacturing Competitiveness Center in partnership with Indiana MEP — provides structured AI readiness assessments and implementation support for manufacturers who cannot self-fund the kind of comprehensive AI program Cummins runs. Typical MEP-assisted pilot engagements for Indiana manufacturers in the $10M-$150M revenue range run $25,000-$80,000 for a single-focus deployment, with Purdue's network providing access to engineering students and faculty who can reduce implementation cost through academic partnership structures. The Indiana Economic Development Corporation's Skill UP Indiana! program has also been used to fund AI workforce training for manufacturers implementing new systems.
Connecting AI systems to existing business infrastructure and workflows
Workflow automation using AI, including Make.com-style automation and RPA
Predictive models, data analysis, and ML pipeline development
Image recognition, object detection, video analysis, and visual inspection systems
Ongoing IT support, managed networks, helpdesk, cybersecurity, and infrastructure management enhanced with AI-driven monitoring and automation
All three OEMs are raising expectations for real-time statistical process control data, electronic traceability records, and AI-assisted defect detection at supplier quality audits. Toyota Princeton's Production System requirements are the most formalized — their Global Production Center audit criteria explicitly evaluate whether suppliers can produce real-time process data rather than batch-reported manual records. Honda Greensburg and Subaru Lafayette are applying similar pressure through their supplier quality programs. Indiana suppliers that cannot demonstrate AI-capable quality systems are increasingly at risk of losing preferred-supplier status during recompete cycles.
FDA's Computer Software Assurance guidance (2022) replaced the older validation approach with a risk-based framework that is actually more favorable to AI deployment — high-risk process control software still needs rigorous validation, but lower-risk AI-assisted monitoring tools can be implemented with lighter documentation overhead. Indiana pharma manufacturers, including Lilly's Lebanon and Clinton facilities and the Indianapolis-area contract manufacturers, should engage AI implementation partners who have delivered FDA-validated deployments and can produce the Installation Qualification and Operational Qualification documentation FDA inspectors expect to find in manufacturing records.
Cummins runs a multi-year AI manufacturing program with dedicated data science staff embedded in their Columbus operations — a resource model that a 100-person Indiana manufacturer cannot replicate directly. What can be replicated is the underlying approach: start with a specific high-cost problem (a weld line with a 3% defect rate, a machining center with chronic tool failure), deploy a focused AI solution on that problem first, build internal capability through the deployment, then expand. Purdue MEP can help smaller Indiana manufacturers structure this phased approach without requiring a Cummins-scale internal investment.
At the tier-one level — companies like Magna Powertrain, BorgWarner, and Haynes International — AI quality and maintenance applications are increasingly integrated with SAP or Oracle manufacturing modules, feeding real-time defect and downtime data into enterprise reporting. At the tier-two level, standalone deployments are still the norm. Integration with ERP adds 30-50% to implementation cost and timeline but is increasingly expected by OEM customers who want supply chain visibility into real-time production status. Purdue MEP's assessment process specifically evaluates ERP integration readiness as part of its AI scoping.
OEM-driven quality deadlines — typically delivered via a supplier corrective action request or a supplier development audit with a 6-month compliance window — compress AI implementation timelines significantly. An Indiana auto supplier with a Toyota or Honda audit deadline can typically deploy a focused AI quality inspection or SPC system in 3-5 months if they have clean production data available and do not need major equipment retrofitting. Adding sensor hardware to legacy machines adds 4-6 weeks. Indiana MEP has run expedited assessment programs for OEM-compliance-deadline situations — that is worth asking about if you're under a specific audit window.
Reach Indiana businesses looking for your expertise.